|1|Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands. (24291376)
van Steenbergen L.N.... van de Poll-Franse L.V.
|2|Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer. (23208501)
Pandey P.R.... Watabe K.
|3|Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. (23896274)
Benson J.R.... Wishart G.C.
|4|Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells. (24192633)
Tsukabe M.... Noguchi S.
|5|The management of ductal carcinoma in situ: current controversies and future directions. (23453783)
Masson S.... Bahl A.
|6|Ductal carcinoma inA situ arising in tubular adenoma of the breast. (22700460)
Saimura M.... Toyoshima S.
|7|Adjuvant hormonal therapy use among women with ductal carcinoma in situ. (21902542)
Livaudais J.C.... Kaplan C.P.
|8|A rare case of extensive ductal carcinoma in situ of the breast with secretory features. (23372916)
Sato T.... Sugihara K.
|9|Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer. (21983862)
Wong H.... Yau T.
|10|Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study. (23098066)
Vidali C.... Pietta N.
|11|Asymptomatic Incidental Ductal Carcinoma in situ in a Male Breast Presenting with Contralateral Gynecomastia. (22530182)
Isley L.M.... Bernard J.M.
|12|Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. (22342935)
Macklin P.... Cristini V.
|13|Ductal carcinoma in situ of the breast. (22378935)
Barnes N.L.... Bundred N.J.
|14|Mucocele-like tumor associated with ductal carcinoma in situ diagnosed as mucinous carcinoma by fine-needle aspiration cytology: report of a case. (22237901)
Kikuchi S.... Arima N.
|15|Is ductal carcinoma in situ with "possible invasion" more predictive of invasive carcinoma than pure ductal carcinoma in situ? (21561735)
Arazi-Kleinman T.... Jong R.A.
|16|Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. (21493791)
Brennan M.E.... Houssami N.
|17|Utility of cytokeratin 5/6 and high-molecular-weight keratin in evaluation of cauterized surgical margins in excised specimens of breast ductal carcinoma in situ. (21420886)
Nayak A.... Bhuiya T.A.
|18|Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. (21843942)
Meyerson A.F.... Hwang E.S.
|19|Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer. (21863363)
Kruper L.... Bernstein L.
|20|Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma. (21720115)
Kato F.... Shirato H.
|21|Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. (21710692)
Moelans C.B.... van Diest P.J.
|22|Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast. (21862942)
Usmani S.... Al Kandari F.
|23|Structural estimates of treatment effects on outcomes using retrospective data: an application to ductal carcinoma in situ. (21602195)
Gold H.T.... Dick A.W.
|24|Mammographycally occult high grade ductal carcinoma in situ (DCIS) as second primary breast cancer, detected with MRI: a case report. (22933920)
Zebic-Sinkovec M.... Snoj M.
|25|Proceedings of the National Institutes of Health State-of-the-Science Conference, Diagnosis and Management of Ductal Carcinoma In Situ. September 2009. (21312388) |2010|
|26|Status of Intraductal Therapy for Ductal Carcinoma in Situ. (21124756)
Flanagan M.... Hwang E.S.
|27|Epidemiology of ductal carcinoma in situ. (20956818)
|28|The use of sentinel lymph node biopsy in ductal carcinoma in situ. (20836339)
Schneider C.... Cornett W.
|29|Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer. (20105298)
Tada K.... Iwase T.
|30|Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project. (20152272)
Evans A.... Pinder S.E.
|31|Biomarkers predicting recurrence and progression of ductal carcinoma in situ treated by lumpectomy alone. (20427432)
|32|Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey. (20663616)
Schuh F.... Edelweiss M.I.
|33|The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma inA situ. (19756924)
Hung W.K.... Chan L.K.
|34|Ductal carcinoma in situ: dilemma or denouement. (20368539)
Lagios M.D.... Silverstein M.J.
|35|Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. (20469955)
Haque R.... Habel L.A.
|36|Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome. (19729831)
Yoon N.K.... Goodglick L.
|37|P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. (17123107)
Paredes J.... Schmitt F.C.
|38|The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue. (17126249)
Leo C.... Horn L.C.
|39|Synchronous bilateral ductal carcinoma in situ of the male breast associated with gynecomastia in a 30-year-old patient following repeated injections of stanozolol. (16328719)
Staerkle R.F.... Melcher A.
|40|Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast. (16324200)
Vogl G.... Hauser-Kronberger C.
|41|Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. (15841074)
WA1lfing P.... Kiesel L.
|42|The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. (15160334)
Cornfield D.B.... Schwarting R.
|43|Immunohistochemical expression of uPA, PAI-1, cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast. (12016391)
Zhao H.... Izumi K.
|44|Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection]. (12532908)
MrhalovA! M.... Strnad P.
|45|Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. (11304577)
Kang J.H.... Kang H.S.
|46|Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast. (10502721)
Mommers E.C.... van Diest P.J.
|47|Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23. (10458905)
Wang J.C.... Donis-Keller H.
|48|High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. (8968105)
Man S.... Brook J.D.
|49|Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. (7911998)
Poller D.N.... Ellis I.O.
|50|The classification of ductal carcinoma in situ and its association with biological markers. (7831531)
Bobrow L.G.... Millis R.R.